Nuvation Bio (NUVB) Equity Average (2023 - 2025)
Historic Equity Average for Nuvation Bio (NUVB) over the last 3 years, with Q3 2025 value amounting to $349.4 million.
- Nuvation Bio's Equity Average fell 804.28% to $349.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $349.4 million, marking a year-over-year decrease of 804.28%. This contributed to the annual value of $534.5 million for FY2024, which is N/A changed from last year.
- According to the latest figures from Q3 2025, Nuvation Bio's Equity Average is $349.4 million, which was down 804.28% from $396.2 million recorded in Q2 2025.
- Nuvation Bio's Equity Average's 5-year high stood at $632.9 million during Q2 2023, with a 5-year trough of $349.4 million in Q3 2025.
- In the last 3 years, Nuvation Bio's Equity Average had a median value of $462.4 million in 2024 and averaged $493.5 million.
- Per our database at Business Quant, Nuvation Bio's Equity Average tumbled by 3852.98% in 2024 and then crashed by 691.56% in 2025.
- Nuvation Bio's Equity Average (Quarter) stood at $608.4 million in 2023, then fell by 20.56% to $483.3 million in 2024, then decreased by 27.7% to $349.4 million in 2025.
- Its Equity Average stands at $349.4 million for Q3 2025, versus $396.2 million for Q2 2025 and $441.6 million for Q1 2025.